CRISPR Therapeutics AG(CRSP)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CRSP CRISPR Therapeutics AG

盘后交易 07-22 16:34:12 EDT

56.24

+1.68

+3.08%

盘后56.20

-0.04-0.07%

16:27 EDT

最高56.39	最低54.06	成交量120.77万
今开55.20	昨收54.56	日振幅4.27%
总市值47.76亿	流通市值46.89亿	总股本8,492万
成交额6,696万	换手率1.45%	流通股本8,337万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"CRSP","market":"US","secType":"STK","nameCN":"CRISPR Therapeutics AG","latestPrice":56.24,"timestamp":1721678400000,"preClose":54.56,"halted":0,"volume":1207703,"hourTrading":{"tag":"盘后","latestPrice":56.2,"preClose":56.24,"latestTime":"16:27 EDT","volume":20860,"amount":1173169.86276,"timestamp":1721680069347},"delay":0,"floatShares":83373747,"shares":84918093,"eps":-2.724255,"marketStatus":"盘后交易","marketStatusCode":4,"change":1.68,"latestTime":"07-22 16:34:12 EDT","open":55.2,"high":56.39,"low":54.06,"amount":66962189.429324,"amplitude":0.042705,"askPrice":56.24,"askSize":50,"bidPrice":56.08,"bidSize":60,"shortable":3,"etf":0,"ttmEps":-2.724255,"exchange":"NASDAQ","tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1721692800000},"adr":0,"listingDate":1476849600000,"adjPreClose":54.56,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":55,"preClose":54.56,"latestTime":"09:27 EDT","volume":1489,"amount":82237.094772,"timestamp":1721654870077},"postHourTrading":{"tag":"盘后","latestPrice":56.2,"preClose":56.24,"latestTime":"16:27 EDT","volume":20860,"amount":1173169.86276,"timestamp":1721680069347},"volumeRatio":0.668311,"impliedVol":0.6387,"impliedVolPercentile":0.5976},"requestUrl":"/m/hq/s/CRSP/tweets","defaultTab":"tweets","newsList":[{"id":"2452436726","title":"Crispr Therapeutics Ag盘中异动 快速下挫5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2452436726","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452436726?lang=zh_cn&edition=full","pubTime":"2024-07-18 23:54","pubTimestamp":1721318047,"startTime":"0","endTime":"0","summary":"北京时间2024年07月18日23时54分，Crispr Therapeutics Ag股票出现波动，股价大幅跳水5.07%。Crispr Therapeutics Ag股票所在的生物技术行业中，整体跌幅为2.04%。Crispr Therapeutics Ag公司简介：Crispr Therapeutics 是一家基因编辑公司，专注于开发基于 CRISPR/Cas9 的疗法。Crispr 的第一个获批药物是 Casgevy，该药物是与 Vertex Pharmaceuticals 合作开发的，针对镰状细胞病和输血依赖性β地中海贫血，这些疾病的医疗需求尚未得到满足。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407182354089681e1db&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407182354089681e1db&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRSP","BK4139","LU1861558580.USD","BK4556","LENZ","BK4585","LU1861559042.SGD","BK4588"],"gpt_icon":0},{"id":"2451913902","title":"Crispr Therapeutics Ag盘中异动 早盘快速上涨5.13%报60.41美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2451913902","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451913902?lang=zh_cn&edition=full","pubTime":"2024-07-16 21:53","pubTimestamp":1721138027,"startTime":"0","endTime":"0","summary":"北京时间2024年07月16日21时53分，Crispr Therapeutics Ag股票出现异动，股价急速拉升5.13%。截至发稿，该股报60.41美元/股，成交量19.3162万股，换手率0.23%，振幅4.99%。Crispr Therapeutics Ag股票所在的生物技术行业中，整体涨幅为0.61%。Crispr Therapeutics Ag公司简介：Crispr Therapeutics 是一家基因编辑公司，专注于开发基于 CRISPR/Cas9 的疗法。Crispr 的第一个获批药物是 Casgevy，该药物是与 Vertex Pharmaceuticals 合作开发的，针对镰状细胞病和输血依赖性β地中海贫血，这些疾病的医疗需求尚未得到满足。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407162153479681d327&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407162153479681d327&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRSP","BK4588","LU1861559042.SGD","BK4139","LENZ","LU1861558580.USD","BK4556","BK4585"],"gpt_icon":0},{"id":"2450935003","title":"Crispr Therapeutics Ag盘中异动 早盘股价大涨5.08%报58.38美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450935003","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450935003?lang=zh_cn&edition=full","pubTime":"2024-07-11 21:34","pubTimestamp":1720704875,"startTime":"0","endTime":"0","summary":"北京时间2024年07月11日21时34分，Crispr Therapeutics Ag股票出现波动，股价快速上涨5.08%。截至发稿，该股报58.38美元/股，成交量12.7061万股，换手率0.15%，振幅2.47%。Crispr Therapeutics Ag股票所在的生物技术行业中，整体跌幅为0.02%。Crispr Therapeutics Ag公司简介：Crispr Therapeutics 是一家基因编辑公司，专注于开发基于 CRISPR/Cas9 的疗法。Crispr 的第一个获批药物是 Casgevy，该药物是与 Vertex Pharmaceuticals 合作开发的，针对镰状细胞病和输血依赖性β地中海贫血，这些疾病的医疗需求尚未得到满足。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407112134369681bffe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407112134369681bffe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","LU1861559042.SGD","LU1861558580.USD","BK4556","BK4588","CRSP","BK4585","BK4139"],"gpt_icon":0},{"id":"2445233050","title":"超越CRISPR，精确切割靶点插入序列，新基因编辑工具SeekRNA面世","url":"https://stock-news.laohu8.com/highlight/detail?id=2445233050","media":"中国科技网","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445233050?lang=zh_cn&edition=full","pubTime":"2024-06-24 17:10","pubTimestamp":1719220206,"startTime":"0","endTime":"0","summary":"如今，澳大利亚悉尼大学生命与环境科学学院团队成功开发出一种比CRISPR更准确、更灵活的基因编辑工具SeekRNA。SeekRNA则能在不使用任何其他蛋白的情况下，精确切割靶点并插入新DNA序列。这使其相对CRISPR来说更加精确可靠，减少了潜在错误。利用这一特性，seekRNA能适应任何基因组序列，并以精确方式插入新DNA。目前，研究人员已经在细菌中成功测试了seekRNA的有效性。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://tech.ifeng.com/c/8afemzyGQAK","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fenghuang_stock","symbols":["LU1861559042.SGD","LU1861558580.USD","BK4556","BK4588","CRSP","BK4585","BK4139"],"gpt_icon":0},{"id":"2445079377","title":"Crispr Therapeutics Ag盘中异动 下午盘股价大跌5.03%报56.60美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2445079377","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445079377?lang=zh_cn&edition=full","pubTime":"2024-06-22 01:57","pubTimestamp":1718992651,"startTime":"0","endTime":"0","summary":"北京时间2024年06月22日01时57分，Crispr Therapeutics Ag股票出现波动，股价快速下挫5.03%。截至发稿，该股报56.60美元/股，成交量88.5289万股，换手率1.04%，振幅6.19%。Crispr Therapeutics Ag股票所在的生物技术行业中，整体涨幅为0.25%。Crispr Therapeutics Ag公司简介：Crispr Therapeutics 是一家基因编辑公司，专注于开发基于 CRISPR/Cas9 的疗法。Crispr 的第一个获批药物是 Casgevy，该药物是与 Vertex Pharmaceuticals 合作开发的，针对镰状细胞病和输血依赖性β地中海贫血，这些疾病的医疗需求尚未得到满足。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062201573196815d4e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062201573196815d4e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","LENZ","BK4585","LU1861558580.USD","BK4556","BK4139","CRSP","LU1861559042.SGD"],"gpt_icon":0},{"id":"2442310030","title":"Crispr Therapeutics Ag盘中异动 下午盘快速上涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2442310030","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2442310030?lang=zh_cn&edition=full","pubTime":"2024-06-12 02:21","pubTimestamp":1718130068,"startTime":"0","endTime":"0","summary":"北京时间2024年06月12日02时21分，Crispr Therapeutics Ag股票出现波动，股价大幅上涨5.00%。Crispr Therapeutics Ag股票所在的生物技术行业中，整体涨幅为0.01%。Crispr Therapeutics Ag公司简介：Crispr Therapeutics 是一家基因编辑公司，专注于开发基于 CRISPR/Cas9 的疗法。Crispr 的第一个获批药物是 Casgevy，该药物是与 Vertex Pharmaceuticals 合作开发的，针对镰状细胞病和输血依赖性β地中海贫血，这些疾病的医疗需求尚未得到满足。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240612022109aef45f86&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240612022109aef45f86&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1861558580.USD","LENZ","BK4139","BK4585","CRSP","BK4588","LU1861559042.SGD","BK4556"],"gpt_icon":0},{"id":"2440957464","title":"Crispr Therapeutics Ag盘中异动 股价大涨5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2440957464","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2440957464?lang=zh_cn&edition=full","pubTime":"2024-06-03 21:41","pubTimestamp":1717422071,"startTime":"0","endTime":"0","summary":"北京时间2024年06月03日21时41分，Crispr Therapeutics Ag股票出现波动，股价急速拉升5.04%。Crispr Therapeutics Ag股票所在的生物技术行业中，整体涨幅为0.33%。Crispr Therapeutics Ag公司简介：Crispr Therapeutics 是一家基因编辑公司，专注于开发基于 CRISPR/Cas9 的疗法。Crispr 的第一个获批药物是 Casgevy，该药物是与 Vertex Pharmaceuticals 合作开发的，针对镰状细胞病和输血依赖性β地中海贫血，这些疾病的医疗需求尚未得到满足。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240603214111941ebe5c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240603214111941ebe5c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","CRSP","BK4588","LU1861559042.SGD","BK4585","LU1861558580.USD","BK4556","BK4139"],"gpt_icon":0},{"id":"2440128599","title":"Intellia Therapeutics公布了正在进行的Ntla-2002的1期研究的积极长期数据Ntla-2002是一种用于遗传性血管性水肿（Hae）的在研CRISPR基因编辑疗法","url":"https://stock-news.laohu8.com/highlight/detail?id=2440128599","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2440128599?lang=zh_cn&edition=full","pubTime":"2024-06-02 20:05","pubTimestamp":1717329953,"startTime":"0","endTime":"0","summary":"Intellia Therapeutics公布了正在进行的Ntla-2002的1期研究的积极长期数据Ntla-2002是一种用于遗传性血管性水肿（Hae）的在研CRISPR基因编辑疗法","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406022005539f11ff88&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406022005539f11ff88&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","CRSP","BK4556","BK4535","BK4139","BK4585","BK4588","LU1861559042.SGD","LU1861558580.USD","NTLA"],"gpt_icon":0},{"id":"2437796946","title":"花旗：维持CRISPR Therapeutics(CRSP.US)评级，由买入调整至买入评级, 目标价由89.00美元调整至84.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2437796946","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2437796946?lang=zh_cn&edition=full","pubTime":"2024-05-24 01:35","pubTimestamp":1716485720,"startTime":"0","endTime":"0","summary":"花旗：维持CRISPR Therapeutics(CRSP.US)评级，由买入调整至买入评级, 目标价由89.00美元调整至84.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405240135229ede4307&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405240135229ede4307&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRSP","LENZ","C"],"gpt_icon":0},{"id":"2437291591","title":"Crispr Therapeutics Ag盘中异动 急速上涨5.00%报57.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2437291591","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2437291591?lang=zh_cn&edition=full","pubTime":"2024-05-22 22:22","pubTimestamp":1716387779,"startTime":"0","endTime":"0","summary":"北京时间2024年05月22日22时22分，Crispr Therapeutics Ag股票出现异动，股价大幅上涨5.00%。截至发稿，该股报57.50美元/股，成交量21.3249万股，换手率0.25%，振幅5.48%。Crispr Therapeutics Ag股票所在的生物技术行业中，整体涨幅为0.24%。Crispr Therapeutics Ag公司简介：Crispr Therapeutics 是一家基因编辑公司，专注于开发基于 CRISPR/Cas9 的疗法。Crispr 的第一个获批药物是 Casgevy，该药物是与 Vertex Pharmaceuticals 合作开发的，针对镰状细胞病和输血依赖性β地中海贫血，这些疾病的医疗需求尚未得到满足。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240522222259941e9749&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240522222259941e9749&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","LU1861559042.SGD","LU1861558580.USD","CRSP","BK4585","BK4588","BK4556","BK4139"],"gpt_icon":0},{"id":"2435145386","title":"张锋公司又被收购","url":"https://stock-news.laohu8.com/highlight/detail?id=2435145386","media":"经济观察网","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435145386?lang=zh_cn&edition=full","pubTime":"2024-05-16 09:49","pubTimestamp":1715824140,"startTime":"0","endTime":"0","summary":"近日，基因编辑公司Arbor Biotechnologies宣布收购一家基因编辑初创公司Serendipity Biosciences。Arbor将获得后者现有的创新资产，包括基于Fanzor、IsrB和其他未公开的可编程编辑技术，补充和扩展了其现有的编辑能力。双方并未公布具体财务细节。　　其中，在Arbor和Serendipity的创始团队中，都能看到联合创始人张锋的身影。Arbor由张锋和哈佛大学David Walt博士等共同创立，Serendipity则是由张锋联合麻省理工学院科学家一同创立。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/yjdt/2024-05-16/doc-inavkuir2279266.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/yjdt/2024-05-16/doc-inavkuir2279266.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["CRSP","BK4556","BK4139","BK4585","BK4588","LU1861559042.SGD","LU1861558580.USD"],"gpt_icon":0},{"id":"2435373920","title":"Crispr Therapeutics Ag盘中异动 早盘股价大涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2435373920","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435373920?lang=zh_cn&edition=full","pubTime":"2024-05-13 21:35","pubTimestamp":1715607318,"startTime":"0","endTime":"0","summary":"北京时间2024年05月13日21时35分，Crispr Therapeutics Ag股票出现波动，股价大幅拉升5.00%。Crispr Therapeutics Ag股票所在的生物技术行业中，整体涨幅为0.90%。Crispr Therapeutics Ag公司简介：Crispr Therapeutics 是一家基因编辑公司，专注于开发基于 CRISPR/Cas9 的疗法。Crispr 的第一个获批药物是 Casgevy，该药物是与 Vertex Pharmaceuticals 合作开发的，针对镰状细胞病和输血依赖性β地中海贫血，这些疾病的医疗需求尚未得到满足。该信息摘要如下：奥本海默：维持CRISPR Therapeutics评级，由优于大市调整至优于大市评级, 目标价由102.00美元调整至95.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405132135197a599aa6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405132135197a599aa6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","LU1861559042.SGD","LU1861558580.USD","BK4556","BK4588","CRSP","BK4585","BK4139"],"gpt_icon":0},{"id":"2434864897","title":"奥本海默：维持CRISPR Therapeutics(CRSP.US)评级，由优于大市调整至优于大市评级, 目标价由102.00美元调整至95.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2434864897","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2434864897?lang=zh_cn&edition=full","pubTime":"2024-05-11 00:55","pubTimestamp":1715360121,"startTime":"0","endTime":"0","summary":"奥本海默：维持CRISPR Therapeutics(CRSP.US)评级，由优于大市调整至优于大市评级, 目标价由102.00美元调整至95.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405110055228751854d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405110055228751854d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRSP","LENZ"],"gpt_icon":0},{"id":"2434134540","title":"Needham：维持CRISPR Therapeutics(CRSP.US)评级，由买入调整至买入评级, 目标价由90.00美元调整至88.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2434134540","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2434134540?lang=zh_cn&edition=full","pubTime":"2024-05-09 21:46","pubTimestamp":1715262388,"startTime":"0","endTime":"0","summary":"Needham：维持CRISPR Therapeutics(CRSP.US)评级，由买入调整至买入评级, 目标价由90.00美元调整至88.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405092146328aed16cc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405092146328aed16cc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRSP","LENZ"],"gpt_icon":0},{"id":"2434577050","title":"Crispr Therapeutics Ag盘中异动 大幅下挫5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2434577050","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2434577050?lang=zh_cn&edition=full","pubTime":"2024-05-09 03:06","pubTimestamp":1715195206,"startTime":"0","endTime":"0","summary":"北京时间2024年05月09日03时06分，Crispr Therapeutics Ag股票出现异动，股价快速跳水5.10%。Crispr Therapeutics Ag股票所在的生物技术行业中，整体跌幅为0.56%。Crispr Therapeutics Ag公司简介：Crispr Therapeutics 是一家基因编辑公司，专注于开发基于 CRISPR/Cas9 的疗法。Crispr 的第一个获批药物是 Casgevy，该药物是与 Vertex Pharmaceuticals 合作开发的，针对镰状细胞病和输血依赖性β地中海贫血，这些疾病的医疗需求尚未得到满足。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050903064687e86807&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050903064687e86807&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","BK4556","LU1861559042.SGD","BK4585","LU1861558580.USD","BK4588","CRSP"],"gpt_icon":0},{"id":"2433741881","title":"朝气蓬勃的千亿新赛道","url":"https://stock-news.laohu8.com/highlight/detail?id=2433741881","media":"格隆汇","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2433741881?lang=zh_cn&edition=full","pubTime":"2024-05-08 18:56","pubTimestamp":1715165803,"startTime":"0","endTime":"0","summary":"还能追吗？","market":"hk","thumbnail":"https://img3.gelonghui.com/134a9-c01674fa-e7e7-495e-abd9-02ae3ddc6182.jpg?guru_height=800&guru_width=1280","type":0,"news_type":0,"thumbnails":["https://img3.gelonghui.com/134a9-c01674fa-e7e7-495e-abd9-02ae3ddc6182.jpg?guru_height=800&guru_width=1280"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/727759","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["BK0226","BK4139","BK4090","CAGR","ZY","AMRSQ","BK4109","BK4159","BK4588","BK4585","BK4556","CRSP","LU1861558580.USD","LU1861559042.SGD","BK4539","603739"],"gpt_icon":0},{"id":"2432706659","title":"Crispr Therapeutics Ag盘中异动 早盘大幅上涨5.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2432706659","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2432706659?lang=zh_cn&edition=full","pubTime":"2024-05-03 21:31","pubTimestamp":1714743060,"startTime":"0","endTime":"0","summary":"北京时间2024年05月03日21时31分，Crispr Therapeutics Ag股票出现波动，股价快速拉升5.27%。Crispr Therapeutics Ag股票所在的生物技术行业中，整体涨幅为0.06%。Crispr Therapeutics Ag公司简介：Crispr Therapeutics 是一家基因编辑公司，专注于开发基于 CRISPR/Cas9 的疗法。Crispr 的第一个获批药物是 Casgevy，该药物是与 Vertex Pharmaceuticals 合作开发的，针对镰状细胞病和输血依赖性β地中海贫血，这些疾病的医疗需求尚未得到满足。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405032131007a57fb05&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405032131007a57fb05&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1861558580.USD","BK4588","LENZ","BK4585","CRSP","BK4556","BK4139","LU1861559042.SGD"],"gpt_icon":0},{"id":"2432357526","title":"Crispr Therapeutics Ag盘中异动 快速上涨5.00%报55.64美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2432357526","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2432357526?lang=zh_cn&edition=full","pubTime":"2024-05-02 02:58","pubTimestamp":1714589915,"startTime":"0","endTime":"0","summary":"北京时间2024年05月02日02时58分，Crispr Therapeutics Ag股票出现异动，股价快速上涨5.00%。截至发稿，该股报55.64美元/股，成交量78.0638万股，换手率0.92%，振幅5.36%。Crispr Therapeutics Ag股票所在的生物技术行业中，整体涨幅为2.21%。Crispr Therapeutics Ag公司简介：Crispr Therapeutics 是一家基因编辑公司，专注于开发基于 CRISPR/Cas9 的疗法。Crispr 的第一个获批药物是 Casgevy，该药物是与 Vertex Pharmaceuticals 合作开发的，针对镰状细胞病和输血依赖性β地中海贫血，这些疾病的医疗需求尚未得到满足。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405020258357925a4f3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405020258357925a4f3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4588","BK4139","BK4556","LU1861559042.SGD","CRSP","LU1861558580.USD","BK4585"],"gpt_icon":0},{"id":"2431394750","title":"又一张百亿牌桌要翻？","url":"https://stock-news.laohu8.com/highlight/detail?id=2431394750","media":"陈广晶","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2431394750?lang=zh_cn&edition=full","pubTime":"2024-04-30 17:24","pubTimestamp":1714469052,"startTime":"0","endTime":"0","summary":"人类科学家再遭降维打击。","market":"us","thumbnail":"https://img.huxiucdn.com/article/cover/202404/30/130915927869.jpg?imageView2/1/w/720/h/405/|imageMogr2/strip/interlace/1/quality/85/format/jpg","type":0,"news_type":0,"thumbnails":["https://img.huxiucdn.com/article/cover/202404/30/130915927869.jpg?imageView2/1/w/720/h/405/|imageMogr2/strip/interlace/1/quality/85/format/jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.huxiu.com/article/2971322.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_huxiu","symbols":["CRSP","BK4588","LU1861559042.SGD","BK4139","LU1861558580.USD","BK4556","BK4585"],"gpt_icon":0},{"id":"2430287896","title":"Crispr Therapeutics Ag盘中异动 股价大跌5.03%报52.85美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2430287896","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2430287896?lang=zh_cn&edition=full","pubTime":"2024-04-25 22:41","pubTimestamp":1714056060,"startTime":"0","endTime":"0","summary":"北京时间2024年04月25日22时41分，Crispr Therapeutics Ag股票出现波动，股价快速跳水5.03%。截至发稿，该股报52.85美元/股，成交量36.7655万股，换手率0.43%，振幅2.32%。Crispr Therapeutics Ag股票所在的生物技术行业中，整体跌幅为1.86%。Crispr Therapeutics Ag公司简介：Crispr Therapeutics 是一家基因编辑公司，专注于开发基于 CRISPR/Cas9 的疗法。Crispr 的第一个获批药物是 Casgevy，该药物是与 Vertex Pharmaceuticals 合作开发的，针对镰状细胞病和输血依赖性β地中海贫血，这些疾病的医疗需求尚未得到满足。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042522410087e83c52&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042522410087e83c52&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1861558580.USD","LENZ","BK4139","BK4585","CRSP","BK4588","LU1861559042.SGD","BK4556"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.crisprtx.com","stockEarnings":[{"period":"1week","weight":-0.0577},{"period":"1month","weight":-0.0992},{"period":"3month","weight":-0.0089},{"period":"6month","weight":-0.1199},{"period":"1year","weight":-0.035},{"period":"ytd","weight":-0.1284}],"compareEarnings":[{"period":"1week","weight":-0.0196},{"period":"1month","weight":0.0009},{"period":"3month","weight":0.1087},{"period":"6month","weight":0.138},{"period":"1year","weight":0.2141},{"period":"ytd","weight":0.155}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"CRISPR Therapeutics AG作为一家瑞士股份公司在Inception Genomics AG名下于2013年10月31日注册成立。他们是一家领先的基因研究的公司，专注于CRISPR/Cas9的疗法发展。 CRISPR/ Cas9代表集群，定期相互间隔短回文重复（CRISPR）相关蛋白9，是改变基因的编排，基因组DNA的特定序列过程中的一项革命性的技术。他们正在应用此技术通过破坏，纠正或调节与疾病相关的基因来治疗广泛的稀有或常见的疾病。他们最先进的项目是针对β-地中海贫血和镰状细胞病，这种病症的治疗需要两个满足高医疗需求的血红蛋白。","yearOnYearQuotes":[{"month":1,"riseRate":0.625,"avgChangeRate":0.090159},{"month":2,"riseRate":0.625,"avgChangeRate":0.089566},{"month":3,"riseRate":0.25,"avgChangeRate":-0.077241},{"month":4,"riseRate":0.625,"avgChangeRate":-0.022564},{"month":5,"riseRate":0.625,"avgChangeRate":0.107663},{"month":6,"riseRate":0.75,"avgChangeRate":0.098677},{"month":7,"riseRate":0.75,"avgChangeRate":0.019551},{"month":8,"riseRate":0.571429,"avgChangeRate":0.019414},{"month":9,"riseRate":0.142857,"avgChangeRate":-0.107923},{"month":10,"riseRate":0.428571,"avgChangeRate":-0.054271},{"month":11,"riseRate":0.75,"avgChangeRate":0.223716},{"month":12,"riseRate":0.25,"avgChangeRate":-0.050604}],"exchange":"NASDAQ","name":"CRISPR Therapeutics AG","nameEN":"CRISPR Therapeutics AG"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"CRISPR Therapeutics AG(CRSP)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供CRISPR Therapeutics AG(CRSP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"CRISPR Therapeutics AG,CRSP,CRISPR Therapeutics AG股票,CRISPR Therapeutics AG股票老虎,CRISPR Therapeutics AG股票老虎国际,CRISPR Therapeutics AG行情,CRISPR Therapeutics AG股票行情,CRISPR Therapeutics AG股价,CRISPR Therapeutics AG股市,CRISPR Therapeutics AG股票价格,CRISPR Therapeutics AG股票交易,CRISPR Therapeutics AG股票购买,CRISPR Therapeutics AG股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"CRISPR Therapeutics AG(CRSP)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供CRISPR Therapeutics AG(CRSP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}